Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chris Bode
Institution:
Absorption Systems (United States)
Observed institution:
Absorption Systems (United States)
ORCID:
0000-0003-3074-9920
Observed ORCID:
0000-0003-3074-9920
OpenAlex ID:
A5031796144
A novel in vitro system, the integrated discrete multiple organ cell culture (IdMOC) system, for the evaluation of human drug toxicity: comparative cytotoxicity of tamoxifen towards normal human cells from five major organs and MCF-7 adenocarcinoma breast cancer cells
2004
·
Albert P. Li
, Chris Bode
, et al.
·
Chemico-Biological Interactions
·
123
Use of Transporter Knockdown Caco-2 Cells to Investigate the In Vitro Efflux of Statin Drugs
2011
·
Jibin Li
, Donna A. Volpe
, et al.
·
Drug Metabolism and Disposition
·
113
The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers
2015
·
Alan Parr
, Ismael J. Hidalgo
, et al.
·
Pharmaceutical Research
·
79
PDF
Regulatory utility of physiologically‐based pharmacokinetic modeling to support alternative bioequivalence approaches and risk assessment: A workshop summary report
2022
·
Fang Wu
, Youssef Mousa
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
30
PDF
The nasty surprise of a complex drug–drug interaction
2010
·
Chris Bode
·
Drug Discovery Today
·
23
Application of exogenous mixture of glutathione and stable isotope labeled glutathione for trapping reactive metabolites in cryopreserved human hepatocytes. Detection of the glutathione conjugates using high resolution accurate mass spectrometry
2013
·
Igor Mezine
, Chris Bode
, et al.
·
Chemico-Biological Interactions
·
12
Principles and Experimental Considerations for In Vitro Transporter Interaction Assays
2014
·
Sid Bhoopathy
, Chris Bode
, et al.
·
Methods in molecular biology
·
11
Antioxidants had No Effects on the In-Vitro Permeability of BCS III Model Drug Substances
2024
·
Dongmei Lu
, Bhagwant Rege
, et al.
·
Journal of Pharmaceutical Sciences
·
8
PDF
Principles and Experimental Considerations for In Vitro Transporter Interaction Assays
2021
·
Sid Bhoopathy
, Chris Bode
, et al.
·
Methods in molecular biology
·
4
Case Study 6. Transporter Case Studies: In Vitro Solutions for Translatable Outcomes
2014
·
Sid Bhoopathy
, Chris Bode
, et al.
·
Methods in molecular biology
·
3
Case Study 7: Transporters Case Studies—In Vitro Solutions for Translatable Outcomes
2021
·
Sid Bhoopathy
, Chris Bode
, et al.
·
Methods in molecular biology
·
2
In Vitro Characterization of Intestinal Transporter, Breast Cancer Resistance Protein (BCRP)
2013
·
Chris Bode
, Li-Bin Li
·
Methods in pharmacology and toxicology
·
1
Malignant transformation of sacrococcygeal teratoma versus presacral teratoma in Currarino syndrome: Results of ‘The SCT-study’
2026
·
Lieke J. van Heurn
, Joep P.M. Derikx
, et al.
·
Journal of Pediatric Surgery
PDF
Perils and Pitfalls of in Vitro Drug Transporter Assays: Common Mistakes to Avoid in Order to Improve Translation of Interaction Data to the Clinic
2013
·
Chris Bode
·
Genetic Engineering & Biotechnology News
Silencing of breast cancer resistance protein expression by lentiviral shRNA transduction particles in Caco-2 cells
2006
·
Wen Zhang
, Robert Strab
, et al.
Show more works
View as search
Works count:
15
Citation count:
409
H-index:
8
I10-index:
7
Year
Topic
Type